APR 12, 2019 8:15 AM PDT

Pulmonary Hypertension in Sarcoidosis

WRITTEN BY: Dena Aruta

Sarcoidosis is an inflammatory disease that involves the formation of non-caseating granulomas, a cluster of macrophages, in response to a foreign substance or antigen in the body, They can be found in any organ system, but 90% of people diagnosed have it in their lungs. The granulomas (also called nodules) can be found in the interstitial tissues (around the air sacs), thoracic lymph nodes, and the vascular system of the lungs.

Pulmonary arterial hypertension (PAH) is increased pulmonary arterial pressure that is characterized by increased pulmonary vascular resistance that can lead to failure of the right ventricle of the heart. It can be life-threatening if not treated. PAH is seen as a complication in sarcoidosis from 5-28% of patients and at rates as high as 74% of those with advanced disease. Sarcoidosis-associated PAH has been shown to worsen its prognosis and may increase the risk of death 7-fold. 

Management of PAH in sarcoidosis is not well understood, and there are currently no specific treatments approved. Kishan Parikh and colleagues published the results of their study on patient characteristics, clinical outcomes, treatment, and management strategies of sarcoidosis-associated PAH  in the journal, Scientific Reports. They followed a large cohort of biopsy-proven sarcoidosis patients with PAH from Duke University for 11 years. "Our primary outcomes of interest were change in 6-minute walk distance (6MWD) and change in N-terminal pro-brain natriuretic peptide (NT-proBNP) by after therapy," states Dr. Parikh. 

Out of the 95 participants who met the criteria for the study, 70% had stage IV pulmonary sarcoidosis, and 77% had functional class III/IV symptoms (marked or severe activity limitations and comfortable only at rest). The median NT-proBNP value was elevated (910 pg/mL), and right ventricular dysfunction was moderate/severe in 55% of patients. The mortality rate over an average of three years was 32% with a mean time to hospitalization or death at six months. 

The authors report three major findings: (1) high morbidity that reflects the disease burden with both pulmonary hypertension and stage IV pulmonary sarcoidosis, (2) no change in the six-minute walk test with PAH-specific treatment, and (3) 37 patients receiving PAH-specific therapy had a 51% improvement in their NT-proBNP. 

In this lecture by Dr. Maddipati from the Division of Pulmonary and Critical Care Medicine at East Carolina University, he gives an overview of sarcoidosis-associated PAH and current treatment strategies. Ultimately, patients who are diagnosed with sarcoidosis-associated PAH should be evaluated for possible lung transplantation. 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
AUG 24, 2021
Health & Medicine
Do "brain trainers" make you smarter? Maybe, maybe not.
AUG 24, 2021
Do "brain trainers" make you smarter? Maybe, maybe not.
There is no consensus about the efficacy of online cognitive games, but a recent study found no cognitive improvements a ...
AUG 24, 2021
Plants & Animals
Flanged male orangutans experience more severe early life stress
AUG 24, 2021
Flanged male orangutans experience more severe early life stress
Linear enamel hypoplasia, or LEH, occurs when tooth enamel fails to develop correctly during growth. When the enamel sto ...
AUG 31, 2021
Clinical & Molecular DX
How Quickly Will Alzheimer's Progress? Inflammatory Proteins Have the Answers.
AUG 31, 2021
How Quickly Will Alzheimer's Progress? Inflammatory Proteins Have the Answers.
Alzheimer's is a neurodegenerative disease that affects over 26 million worldwide and is associated with memory prob ...
AUG 28, 2021
Neuroscience
Virtual Reality Reduces Pain in Children During Medical Procedures
AUG 28, 2021
Virtual Reality Reduces Pain in Children During Medical Procedures
Virtual reality (VR) reduces pain and anxiety in children undergoing medical procedures. The corresponding study was pub ...
SEP 06, 2021
Cancer
A New Biomarker to Personalize Breast Cancer Therapy
SEP 06, 2021
A New Biomarker to Personalize Breast Cancer Therapy
The American Cancer Society estimates that over 280,000 women in the United States will be diagnosed with breast cancer ...
SEP 14, 2021
Technology
Dental Implant Produces Its Own Electricity And Fights Bacteria
SEP 14, 2021
Dental Implant Produces Its Own Electricity And Fights Bacteria
The use of dental implants offers a long term, effective treatment approach for lost or missing teeth compared to method ...
Loading Comments...